Response to "Comments on 'Zhang et al: Clinical trial analysis of 2019-nCoV therapy registered in China'"

J Med Virol. 2020 Jul;92(7):713. doi: 10.1002/jmv.25803. Epub 2020 Apr 25.

Authors

Qi Zhang¹, Yakun Wang¹, Changsong Qi¹, Lin Shen¹, Jian Li¹

Affiliation

¹ Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.

PMID: 32232977
DOI: 10.1002/jmv.25803

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus*
COVID-19
China
Clinical Trials as Topic
Coronavirus Infections*
Humans
Pandemics
Pneumonia, Viral*
SARS-CoV-2